对于2型糖尿病子宫癌患者的存活的机器学习预测模型:一个地区范围的队列研究
Claire Chenwen Zhong1,2, Junjie Huang1,2, Zehuan Yang1,2
1The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
The journal of obstetrics and gynaecology research
|October 1, 2025
概括
这项研究为患有2型糖尿病 (T2D) 的子宫癌患者开发了一种机器学习风险评分,确定了预测生存的关键因素,如年龄和肌素水平. 该系统有助于对患者进行分层,帮助有针对性的临床管理,以改善结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 生物统计学 生物统计学
背景情况:
- 患有2型糖尿病 (T2D) 的子宫癌患者面临复杂的生存挑战.
- 预测模型对于识别风险因素和改善这一群体患者的治疗结果至关重要.
研究的目的:
- 开发2型糖尿病的子宫癌患者的生存预测模型.
- 建立一个风险评分系统,识别关键的生存预测因素.
- 为了估计患者风险分层的生存概率.
主要方法:
- 使用考克斯回归,生存树,LASSO考克斯,提升和随机生存森林 (RSF) 模型.
- 雇员沙普利添加剂 风险因素识别的解释.
- 使用AutoScore-Survival包开发了一个风险评分系统.
主要成果:
- 该RSF模型显示出强大的预测性能 (AUC=0.823,C指数=0.90).
- 确定了关键预测因素:年龄,T2D持续时间,肌,,LDL-C,BMI和甘油三.
- 31.4%的风险评分被归类为高风险,5年生存率为43.5%,明显低于低风险组.
结论:
- 机器学习有效地确定了T2D的子宫癌患者的生存预测因素.
- 开发了一个可临床解释的风险评分系统,分层生存风险.
- 数据驱动的模型可以增强个性化的预测,并指导有针对性的临床管理.
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Survival Tree
388
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
388
Kaplan-Meier Approach
577
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
577
Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561


